Here is the reason why Jaguar Health, Inc. (NASDAQ: JAGX) shares are on the up today
Jaguar Health, Inc. (NASDAQ:JAGX) stock is thriving today as it soared over 44% to reach $3.8 as it revealed in an announcement that the 28-day preclinical test in dogs has begun, January 6, 2021, to support the development of lechlemer, the plant-based drug candidate of Jaguar Health’s wholly-owned subsidiary, Napo Pharmaceuticals, for the relief of […]